{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:03:36Z","timestamp":1778814216050,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.crad.2021.06.001","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T08:06:52Z","timestamp":1625040412000},"page":"789-800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chronic lymphocytic leukaemia and Richter's transformation: multimodal review and new imaging paradigms"],"prefix":"10.1016","volume":"76","author":[{"given":"E.","family":"Musanhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Attygalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Wotherspoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Chau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dearden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"El-Sharkawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2021.06.001_bib1","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","year":"2017"},{"issue":"9","key":"10.1016\/j.crad.2021.06.001_bib2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/ajh.24826","article-title":"Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment","volume":"92","author":"Hallek","year":"2017","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.crad.2021.06.001_bib3","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3324\/haematol.2014.107326","article-title":"Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model","volume":"99","author":"Baumann","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.crad.2021.06.001_bib4a","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bjhh.2017.01.002","article-title":"Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian group of chronic lymphocytic leukemia [published correction appears","volume":"39","author":"Rodrigues","year":"2017","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"4","key":"10.1016\/j.crad.2021.06.001_bib4b","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bjhh.2016.07.004","article-title":"Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian group of chronic lymphocytic leukemia [published correction appears","volume":"38","author":"Rodrigues","year":"2016","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"25","key":"10.1016\/j.crad.2021.06.001_bib5","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.crad.2021.06.001_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.crad.2021.06.001_bib7","series-title":"Chronic lymphocytic leukemia: recent progress and future directions","first-page":"253","article-title":"A critical analysis of staging in CLL","author":"Rai","year":"1987"},{"key":"10.1016\/j.crad.2021.06.001_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.crad.2021.06.001_bib9","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1182\/blood-2005-12-051458","article-title":"Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia","volume":"109","author":"Wierda","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.crad.2021.06.001_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood-2014-02-556399","article-title":"Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia","volume":"124","author":"Pfl ug","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.crad.2021.06.001_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood-2014-05-575407","article-title":"A new prognostic score for CLL","volume":"124","author":"Tam","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.crad.2021.06.001_bib12","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1470-2045(16)30029-8","article-title":"An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data","volume":"17","year":"2016","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.crad.2021.06.001_bib13","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s00277-018-3350-5","article-title":"Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis","volume":"97","author":"Molica","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.crad.2021.06.001_bib14","first-page":"285","article-title":"Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia","volume":"4","author":"Richter","year":"1928","journal-title":"Am J Pathol"},{"key":"10.1016\/j.crad.2021.06.001_bib15","first-page":"621","article-title":"[Chronic lymphoid leukemia secondarily associated with a malignant reticulopathy: Richter\u2019s Syndrome]","volume":"4","author":"Lortholary","year":"1964","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.1016\/j.crad.2021.06.001_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.canep.2019.04.002","article-title":"Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway","volume":"60","author":"Lenartova","year":"2019","journal-title":"Cancer Epidemiol"},{"issue":"10","key":"10.1016\/j.crad.2021.06.001_bib17","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/ajh.24473","article-title":"Histologic transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"91","author":"Agbay","year":"2016","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.crad.2021.06.001_bib18","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1182\/blood-2013-11-516229","article-title":"How we treat Richter syndrome","volume":"123","author":"Parikh","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.crad.2021.06.001_bib19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/bjh.12458","article-title":"Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients","volume":"162","author":"Parikh","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.crad.2021.06.001_bib20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1182\/blood.V94.2.448","article-title":"Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases","volume":"94","author":"Mauro","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.crad.2021.06.001_bib21","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2010-09-302174","article-title":"The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation","volume":"117","author":"Rossi","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.crad.2021.06.001_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/bjh.14177","article-title":"NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome","volume":"175","author":"Eyre","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.crad.2021.06.001_bib23","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3324\/haematol.2019.224121","article-title":"Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center","volume":"105","author":"Wang","year":"2020","journal-title":"Haematologica"},{"issue":"15","key":"10.1016\/j.crad.2021.06.001_bib24","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1200\/JCO.2005.05.0187","article-title":"Clinical outcomes and prognostic factors in patients with Richter\u2019s syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation","volume":"24","author":"Tsimberidou","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.crad.2021.06.001_bib25","doi-asserted-by":"crossref","first-page":"IJH09","DOI":"10.2217\/ijh-2018-0010","article-title":"Current trends in the management of Richter's syndrome","volume":"7","author":"John","year":"2018","journal-title":"Int J Hematol Oncol"},{"issue":"2","key":"10.1016\/j.crad.2021.06.001_bib26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2141.2008.07166.x","article-title":"Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome","volume":"142","author":"Rossi","year":"2008","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.crad.2021.06.001_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11899-007-0036-9","article-title":"Richter's transformation in chronic lymphocytic leukemia","volume":"2","author":"Tsimberidou","year":"2007","journal-title":"Curr Hematol Malig Rep"},{"issue":"6","key":"10.1016\/j.crad.2021.06.001_bib28","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/bjh.12458","article-title":"Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients","volume":"162","author":"Parikh","year":"2013","journal-title":"Br J Haematol"},{"issue":"9583","key":"10.1016\/j.crad.2021.06.001_bib29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(07)61125-8","article-title":"Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial","volume":"370","author":"Catovsky","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.crad.2021.06.001_bib30","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11899-014-0223-4","article-title":"Risk factors for Richter syndrome in chronic lymphocytic leukemia","volume":"9","author":"Parikh","year":"2014","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.crad.2021.06.001_bib31","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1182\/blood-2008-01-129726","article-title":"CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?","volume":"111","author":"Aydin","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.crad.2021.06.001_bib32","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-08-3266","article-title":"Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome","volume":"151","author":"Rossi","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"15","key":"10.1016\/j.crad.2021.06.001_bib33","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood-2013-03-489518","article-title":"Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome","volume":"122","author":"Chigrinova","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.crad.2021.06.001_bib34","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2008.399","article-title":"Telomere length is an independent predictor of survival, treatment requirement and Richter\u2019s syndrome transformation in chronic lymphocytic leukemia","volume":"23","author":"Rossi","year":"2009","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.crad.2021.06.001_bib35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2141.2008.07166.x","article-title":"Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome","volume":"142","author":"Rossi","year":"2008","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.crad.2021.06.001_bib36","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1200\/JCO.1993.11.10.1985","article-title":"Richter's syndrome: a report on 39 patients","volume":"11","author":"Robertson","year":"1993","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.crad.2021.06.001_bib37","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00277-018-3390-x","article-title":"Diagnosis of Richter transformation in chronic lymphocytic leukemia: histology tips the scales","volume":"97","author":"Federmann","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.crad.2021.06.001_bib38","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1600-0609.2006.00738.x","article-title":"Herpes simplex and Epstein\u2013Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine","volume":"77","author":"Mercadal","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.crad.2021.06.001_bib39","doi-asserted-by":"crossref","unstructured":"Parikh SA, Bhusal Y, Fardel SH et\u00a0al. The great imitator: systemic nocardiosis mimicking Richter\u2019s transformation in relapsed chronic lymphocytic leukemia. J Clin Oncol 28:e732\u2013e734.","DOI":"10.1200\/JCO.2010.29.9792"},{"key":"10.1016\/j.crad.2021.06.001_bib40","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ajh.24029","article-title":"Disseminated histoplasmosis as pseudo Richter\u2019s transformation in a patient with chronic lymphocytic leukemia","volume":"90","author":"Jain","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.crad.2021.06.001_bib41","series-title":"Non-Hodgkin\u2019s lymphoma: diagnosis and management. NICE guideline [NG52]. Published: 20","year":"2016"},{"issue":"3","key":"10.1016\/j.crad.2021.06.001_bib42","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1148\/rg.2020190198","article-title":"Breast implant-associated anaplastic large cell lymphoma: review and multiparametric imaging paradigms","volume":"40","author":"Sharma","year":"2020","journal-title":"RadioGraphics"},{"key":"10.1016\/j.crad.2021.06.001_bib43","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/cncr.20251","article-title":"The clinical significance of large cells in bone marrow in patients with chronic lymphocytic leukemia","volume":"100","author":"Ma","year":"2004","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.crad.2021.06.001_bib44","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/ajh.24473","article-title":"Histologic transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"91","author":"Agbay","year":"2016","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.crad.2021.06.001_bib45","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3324\/haematol.2010.022277","article-title":"Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (\"accelerated\" chronic lymphocytic leukemia) with aggressive clinical behavior","volume":"95","author":"Gin\u00e9","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.crad.2021.06.001_bib46","first-page":"1267","article-title":"Detection of Richter's transformation of chronic lymphocytic leukemia by PET\/CT","volume":"47","author":"Bruzzi","year":"2006","journal-title":"J Nucl Med"},{"issue":"18","key":"10.1016\/j.crad.2021.06.001_bib47","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1182\/blood-2013-11-536169","article-title":"Correlation between FDG\/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia","volume":"123","author":"Falchi","year":"2014","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.crad.2021.06.001_bib48","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1182\/blood.V120.21.3888.3888","article-title":"Role of PET\/CT in the diagnostic work-up of patients with chronic lymphocytic leukemia (CLL) and clinical signs of disease progression","volume":"120","author":"Mauro","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.crad.2021.06.001_bib49","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.3324\/haematol.2018.207068","article-title":"Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy","volume":"104","author":"Mato","year":"2019","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.crad.2021.06.001_bib50","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood-2010-04-282228","article-title":"Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis","volume":"117","author":"Eichhorst","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.crad.2021.06.001_bib51","first-page":"6","article-title":"Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study","volume":"96","author":"Gentile","year":"2015","journal-title":"Eur J Haematol"},{"issue":"12","key":"10.1016\/j.crad.2021.06.001_bib52","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1200\/JCO.2006.08.4194","article-title":"Abdominal computed tomography predicts progression in patients with Rai Stage 0 chronic lymphocytic leukemia","volume":"25","author":"Munta\u00f1ola","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.crad.2021.06.001_bib54","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bjh.15791","article-title":"Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia","volume":"186","author":"Wierda","year":"2019","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.crad.2021.06.001_bib55","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1102\/1470-7330.2009.0017","article-title":"Nodal staging","volume":"9","author":"Ganeshalingam","year":"2009","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.crad.2021.06.001_bib56","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.amjmed.2013.01.009","article-title":"Waxing and waning lymphadenopathy","volume":"126","author":"Sharma","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.crad.2021.06.001_bib57","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1182\/asheducation-2015.1.106","article-title":"lymphadenopathy: benign or malignant?","volume":"2015","author":"Winter","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"7","key":"10.1016\/j.crad.2021.06.001_bib58","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1007\/s00261-015-0451-7","article-title":"Assessing splenic enlargement on CT by unidimensional measurement changes in patients with colorectal liver metastases","volume":"40","author":"Joiner","year":"2015","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.crad.2021.06.001_bib59","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s00261-018-1500-9","article-title":"Spleen enlargement assessment using computed tomography: which coefficient correlates the strongest with the real volume of the spleen?","volume":"43","author":"Kucyba\u0142a","year":"2018","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.crad.2021.06.001_bib60","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/cncr.26380","article-title":"Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response","volume":"118","author":"Pinto","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.crad.2021.06.001_bib61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40644-018-0146-8","article-title":"Review of targeted therapy in chronic lymphocytic leukemia: what a radiologist needs to know about CT interpretation","volume":"18","author":"Gosangi","year":"2018","journal-title":"Cancer Imaging"},{"issue":"4","key":"10.1016\/j.crad.2021.06.001_bib62","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3324\/haematol.2015.136556","article-title":"Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia","volume":"101","author":"Strati","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.crad.2021.06.001_bib63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cyto.b.20032","article-title":"Clinical significance of monoclonal B cells in cerebrospinal fluid","volume":"63","author":"Nowakowski","year":"2005","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.crad.2021.06.001_bib64","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2967\/jnumed.117.206920","article-title":"18F-Fludarabine PET for lymphoma imaging: first-in-humans study on DLBCL and CLL patients","volume":"59","author":"Chantepie","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2021.06.001_bib65","doi-asserted-by":"crossref","first-page":"E7441","DOI":"10.1073\/pnas.1705013114","article-title":"Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma","volume":"114","author":"Tang","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.crad.2021.06.001_bib66","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7150\/thno.11251","article-title":"Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging","volume":"5","author":"Wester","year":"2015","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.crad.2021.06.001_bib67","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.leukres.2010.06.010","article-title":"Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging","volume":"35","author":"Vanderhoek","year":"2011","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.crad.2021.06.001_bib68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.blre.2016.02.003","article-title":"FDG-PET imaging in hematological malignancies","volume":"30","author":"Valls","year":"2016","journal-title":"Blood Rev"},{"issue":"22","key":"10.1016\/j.crad.2021.06.001_bib69","doi-asserted-by":"crossref","first-page":"11055","DOI":"10.1158\/0008-5472.CAN-06-1955","article-title":"Molecular imaging of proliferation in malignant lymphoma","volume":"66","author":"Buck","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.crad.2021.06.001_bib70","first-page":"65","article-title":"Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia","volume":"50","author":"Diop","year":"2005","journal-title":"Dakar Med"},{"issue":"10","key":"10.1016\/j.crad.2021.06.001_bib71","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrclinonc.2017.78","article-title":"Evolution of lymphoma staging and response evaluation: current limitations and future directions","volume":"14","author":"Cunningham","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"10.1016\/j.crad.2021.06.001_bib72","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrclinonc.2012.195","article-title":"Imaging in oncology\u2014over a century of advances","volume":"9","author":"Sharma","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.crad.2021.06.001_bib73","first-page":"1836","article-title":"SUV: standard uptake or silly useless value?","volume":"36","author":"Keyes","year":"1995","journal-title":"J Nuci Med"},{"key":"10.1016\/j.crad.2021.06.001_bib74","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1148\/radiol.09091105","article-title":"Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET\/CT reference for initial staging","volume":"255","author":"Punwani","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2021.06.001_bib75","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/RLI.0b013e3182087b03","article-title":"Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study","volume":"46","author":"Lin","year":"2011","journal-title":"Invest Radiol"},{"key":"10.1016\/j.crad.2021.06.001_bib76","doi-asserted-by":"crossref","first-page":"11044","DOI":"10.1038\/srep11044","article-title":"Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer","volume":"5","author":"Parmar","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.crad.2021.06.001_bib77","doi-asserted-by":"crossref","first-page":"38282","DOI":"10.1038\/srep38282","article-title":"Non-small cell lung cancer: quantitative phenotypic analysis of CT images as a potential marker of prognosis","volume":"6","author":"Song","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.crad.2021.06.001_bib78","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12938-015-0120-7","article-title":"Computer-aided detection (CADe) and diagnosis (CADx) system for lung cancer with likelihood of malignancy","volume":"15","author":"Firmino","year":"2016","journal-title":"Biomed Eng Online"},{"key":"10.1016\/j.crad.2021.06.001_bib79","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1007\/s00330-019-06291-9","article-title":"Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome","volume":"29","author":"Reinert","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2021.06.001_bib80","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1148\/radiol.14131520","article-title":"Nanoparticles for imaging: top or flop?","volume":"273","author":"Kiessling","year":"2014","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.crad.2021.06.001_bib81","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1148\/radiol.13131306","article-title":"Clinical impact of PET\/MR imaging in patients with cancer undergoing same-day PET\/CT: initial experience in 134 patients--a hypothesis-generating exploratory study","volume":"269","author":"Catalano","year":"2013","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.crad.2021.06.001_bib82","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/RLI.0000000000000469","article-title":"[68Ga]Ga-pentixafor PET\/MRI for CXCR4 imaging of chronic lymphocytic leukemia: preliminary results","volume":"53","author":"Mayerhoefer","year":"2018","journal-title":"Invest Radiol"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926021003056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926021003056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:45:03Z","timestamp":1757868303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926021003056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":82,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0009926021003056"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2021.06.001","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic lymphocytic leukaemia and Richter's transformation: multimodal review and new imaging paradigms","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2021.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}